v3.26.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 4   $ 462,358 $ (390,343) $ 72,019
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Mar. 31, 2025 2,135,330 54,585      
Deemed dividend related to issuance of preferred Stock     4,839 (4,839)  
Conversion of preferred stock to common stock (in shares) 42,771 (1,800)      
Exercise of pre-funded warrant to common stock     1,750   1,750
Exercise of warrants (in shares) 142,984        
Stock-based compensation     2,342   2,342
Stock-based compensation (in shares) 30,155        
Issuance of preferred stock, net of issuance cost     6,815   6,815
Issuance of preferred stock, net of issuance cost (in shares)   6,800      
Net loss       (9,227) (9,227)
Balance at Mar. 31, 2025 $ 4   478,104 (404,409) 73,699
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Mar. 31, 2025 2,135,330 54,585      
Balance at Dec. 31, 2024 $ 4   462,358 (390,343) 72,019
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Dec. 31, 2025 6,905,948        
Balance at Dec. 31, 2025 $ 4   519,996 (452,078) 67,922
Balance (in shares) at Dec. 31, 2024 1,919,420 49,585      
Balance (in shares) at Dec. 31, 2025 6,905,948        
Balance (in shares) at Mar. 31, 2026 7,299,026        
Issuance of common stock related to lock up agreement (in shares) 204,851        
Exercise of pre-funded warrant to common stock     1,266   1,266
Exercise of warrants (in shares) 186,998        
Stock-based compensation     1,441   1,441
Stock-based compensation (in shares) 1,229        
Net loss       (8,249) (8,249)
Balance at Mar. 31, 2026 $ 4   $ 522,703 $ (460,327) $ 62,380
Balance (in shares) at Dec. 31, 2025 6,905,948        
Balance (in shares) at Mar. 31, 2026 7,299,026